Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor
The inflammatory process implicates homeostasis disruption and increased production of inflammatory mediators. Myeloid differentiation primary response 88 (MyD88) is an essential protein recruited after lipopolysaccharide (LPS) and interleukin (IL)-1β stimulation, a process that converges in nuclear...
Main Authors: | Sergio Ramírez-Pérez, Luis Alexis Hernández-Palma, Edith Oregon-Romero, Brian Uriel Anaya-Macías, Samuel García-Arellano, Guillermo González-Estevez, José Francisco Muñoz-Valle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/18/4322 |
Similar Items
-
MyD88 dimerization inhibitor ST2825 targets the aggressiveness of synovial fibroblasts in rheumatoid arthritis patients
by: Sergio Ramirez-Perez, et al.
Published: (2023-09-01) -
Targeting MyD88 Downregulates Inflammatory Mediators and Pathogenic Processes in PBMC From DMARDs-Naïve Rheumatoid Arthritis Patients
by: Sergio Ramirez-Perez, et al.
Published: (2021-12-01) -
ST2825, independent of MyD88, induces reactive oxygen species-dependent apoptosis in multiple myeloma cells
by: Hajime Nakamura, et al.
Published: (2024-07-01) -
MyD 88 Polymorphisms in Children Diagnosed with Sepsis
by: Sinem Sarı Gökay, et al.
Published: (2016-12-01) -
Mechanism of MyD88S mediated signal termination
by: Katarzyna Pustelny, et al.
Published: (2022-01-01)